Come up with a name for your new list and we'll add to it:
Padlock Therapeutics was acquired by
Bristol-Myers Squibb on March 23, 2016.
Padlock Therapeutics is a private, Cambridge, Massachusetts-based biotechnology company dedicated to creating new medicines to treat destructive autoimmune diseases. The company leverages the science …